Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: suggest (285), remind (88)

Tongue-tie - patient information

Description: This factsheet explains what tongue-tie is, what the implications of tongue-tie are for both you and your baby, and
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Tongue-tie-780-PIL.pdf

Your child's awake anorectal manometry test - patient information

Description: This factsheet explains what an awake anorectal manometry test is and what it involves, so your child knows what to expect
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Your-childs-awake-anorectal-manometry-test-3500-PIL.pdf

Your child's high-resolution oesophageal manometry test - patient information

Description: This factsheet explains what a high-resolution oesophageal manometry test is and what it involves, so your child knows what to
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Your-childs-high-resolution-oesophageal-manometry-test-3498-PIL.pdf

Alemtuzumab

Description: Chemotherapy Protocol TPLL Regimen Alemtuzumab • TPLL – Alemtuzumab Indication • The treatment of adult patients with TPLL in the first line setting. In
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/TPLL/Alemtuzumab-Ver1.pdf

InP-Cisplatin-Etoposide-Ifosfamide (VIP)

Description: Chemotherapy Protocol GERM CELL CISPLATIN-ETOPOSIDE-IFOSFAMIDE (VIP) Inpatient Regimen Regimen • Germ Cell – InP-Cisplatin-Etoposide-Ifosfamide (VIP) Indication • Metastatic Germ
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Cisplatin-Etoposide-Ifosfamide-VIP.pdf

Sotorasib

Description: A Chemotherapy Protocol for Sotorasib, associated with Lung Cancer.
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Sotorasib.pdf

FoM Research Conference programme - final

Description: Faculty of Medicine Research Conference PROGRAMME Tuesday 14th June 2022 Microsoft Teams TIME EVENT SPEAKER 09.15-09.20 MICROSOFT TEAMS
Url: /Media/Southampton-Clinical-Research/Downloads/FoM-Research-Conference-programme-final.pdf

Docetaxel-Nintedanib v1

Description: Chemotherapy Protocol NSCLC CANCER DOCETAXEL-NINTEDANIB Regimen NSCLC – Docetaxel-Nintedanib Indication Advanced or metastatic NSCLC of adenocarcinoma origin that has progressed
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxel-Nintedanib-v1.pdf

Docetaxel

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) DOCETAXEL (75) Regimen NSCLC – Docetaxel (75) Indication Second line therapy of stage IIIB
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxelver12.pdf

InP-Cisplatin-Ifosfamide-Paclitaxel (TIP) Ver1.2

Description: Chemotherapy Protocol GERM CELL CISPLATIN-IFOSFAMIDE-PACLITAXEL (TIP) Inpatient Regimen Regimen Germ Cell – InP-Cisplatin-Ifosfamide-Paclitaxel (TIP) Indication Relapsed Metastatic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Cisplatin-Ifosfamide-Paclitaxel-TIP-Ver1.2.pdf

31 to 40 of 117

Previous … 2 3 4 5 6 … Next